Princípio
O Teste de detecção de antígeno COVID-19 é um teste de imunoensaio para a detecção rápida e qualitativa da infecção por SARS-CoV-2 em espécimes de esfregaço. Os anticorpos monoclonais anti-SARS-CoV-2 são revestidos na região da linha de teste. Os antígenos de SARS-CoV-2, se presentes nas amostras, irão interagir com os anticorpos monoclonais antiSARS-CoV-2 conjugados com o conjugado de ouro, formando o complexo antígeno-anticorpo. Este complexo migra na membrana por ação capilar, onde será capturado pelo anticorpo monoclonal anti-SARS-CoV-2 revestido na linha teste. Uma linha de teste colorida seria visível na janela de resultados se os antígenos SARS-CoV-2 estivessem presentes na amostra. A intensidade da linha de teste colorida irá variar dependendo da quantidade de antígeno SARS-CoV-2 presente na amostra.

SKU: NCTCAG-01
DISPONIBILIDADE: Esgotado
REMESSA: 1 ou 2 dias úteis de graça
TAMANHO: 25 testes / kit
SENSIBILIDADE: 96,6%
ESPECIFICIDADE: 100%

KIT DE TESTE DE ANTÍGENO MERISCREEN COVID-19
O teste de detecção de antígeno MeriScreen COVID-19 é um teste de ensaio imunocromatográfico rápido para a detecção qualitativa do antígeno SARS-CoV-2 em uma amostra de esfregaço nasofaríngea de um corpo humano.
- REVESTIDO COM ANTICORPO ANTI-SARS-COV-2 MONOCLONAL ALTAMENTE PURIFICADO
- RESULTADOS EM 20 MINUTOS
- A AMOSTRA É SWAB NASOFARÍNGICO
- SENSIBILIDADE: 96,6%
- ESPECIFICIDADE: 100%
Observação:
Os kits listados abaixo são validados apenas com o número de lote mencionado. A responsabilidade pela
consistência lote a lote não é do ICMR.
Critérios mínimos de aceitação de sensibilidade e especificidade dos kits de teste Rapid Ag:
Validado como um teste de ponto de cuidado (POCT) sem transporte para uma configuração de laboratório Sensibilidade: 50% e acima
Especificidade: 95% e acima
Validado em uma configuração de laboratório com amostras coletados em meio de transporte viral (VTM) –
Sensibilidade: 70% e acima
Especificidade: 99% e acima
Testes rápidos baseados em antígenos que são aprovados pela FDA dos EUA podem ser usados diretamente após a devida aprovação de comercialização do DCGI.

Breve metodologia de uso do COVID-19 Ag Respi-Strip (CorisBioConcept):
1. O swab nasofaríngeo e / ou orofaríngeo será coletado do paciente suspeito COVID-19 em meio de transporte viral (VTM).
2. O swab coletado em VTM será levado ao laboratório em condições apropriadas da cadeia de frio.
3. Assim que a amostra for levada para o laboratório, ela precisará ser manuseada em um gabinete de nível BSL-2 para alíquotas, colocando em tampão de lise e carregando a tira de teste.
As etapas 1 e 2 serão realizadas de acordo com a prática padrão seguida para coleta e transporte de amostras para o teste COVID-19 RT-PCR.
A etapa 3 deverá ser realizada de acordo com as instruções do fabricante fornecidas com o kit de teste.
![]() COVID-19 IgG/IgM Rapid Test Kit |
|||
UNCOV-20 | UnScience | 20T/kit | EUR 155 |
Description: COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in serum, plasma, or whole blood. This test consists of two test lines, an IgG line and an IgM line, which is pre-coated with two mouse anti-human monoclonal antibodies separately. During testing, the sample reacts with COVID-19 antigen-coated on conjugated pad. As the complex continues to travel up the strip, the anti-COVID-19 IgM antibodies are bound on the IgM line, and the anti-COVID-19 IgG antibodies are bound on the IgG line. The control(C)line appears when sample has flowed through the strip. The presence of anti-COVID-19 IgM and/or IgG will be indicated by a visible test line in the IgM and IgG region. To serve as a procedural control, the control line should always appear if the test procedure is performed properly and the reagents are working as intended. |
![]() Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | EUR 236 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
![]() Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-40tests | Accu test | 40 tests | EUR 321 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
![]() Panbio™ COVID-19 IgG/IgM Rapid Test |
|||
ICO-T402 | Abbott | 25 Tests/Kit | EUR 220 |
![]() Panbio™ COVID-19 Ag Rapid Test Device |
|||
41FK10 | Abbott | 25 Tests/Kit | EUR 99 |
![]() Panbio™ COVID-19 Ag Rapid Test Device (Nasal) |
|||
41FK11 | Abbott | 25 Tests/Kit | EUR 99 |
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19 |
![]() Purified recombinant COVID-19 (isolate Wuhan-Hu-1) NP protein |
|||
nCoVNP-126V | Creative BioMart | 100ug | EUR 792 |
Description: Purified recombinant COVID-19(isolate Wuhan-Hu-1) NP protein was expressed in HEK293 cells. |
![]() Recombinant COVID-19 (isolate Wuhan-Hu-1) S(ΔTM) protein |
|||
nCoVS-125V | Creative BioMart | 100ug | EUR 792 |
Description: Purified recombinant COVID-19(isolate Wuhan-Hu-1) S(ΔTM) protein was expressed in HEK293 cells. |
![]() Novel Coronavirus COVID-19 (2019-nCoV) Real Time RT-PCR Kit |
|||
RR-0478-02 | Liferiver | 25 tests/kit | EUR 991 |
Description: Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit is used for the qualitative detection of a novel coronavirus, which was identified in 2019 at Wuhan City, Hubei Province, China, in upper respiratory tract specimens (nasopharyngeal extracts, deep cough sputum, etc.) and lower respiratory tract specimens (alveoli irrigation fluid, etc.) by real time PCR systems. |
![]() Cancer Antigen 19-9 Antigen (Liver Carcinoma) |
|||
VAng-Cr3873-10kU | Creative Biolabs | 10 kU | EUR 394 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
![]() TESTO (Testosterone) ELISA test |
|||
19 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of O (osterone) |
![]() Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) |
|||
VAng-Cr3875-25kU | Creative Biolabs | 25 kU | EUR 738 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
![]() Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
|||
CA1991-N-10 | Alpha Diagnostics | 10 KU | EUR 529 |
![]() Cancer Antigen 19-9 Antigen (Liver Carcinoma) (High purity) |
|||
VAng-Cr3874-25kU | Creative Biolabs | 25 kU | EUR 861 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. |
![]() Cancer Antigen CA 19-9 Antibody |
|||
abx023798-1mg | Abbexa | 1 mg | EUR 878 |
![]() Cancer Antigen CA 19-9 Antigen (Human metastatic liver carcinoma) |
|||
VAng-Wyb8635-inquire | Creative Biolabs | inquire | Ask for price |
Description: CA 19-9 (Gastrointestinal Cancer), Antigen Grade, Cancer antigen from Human metastatic liver carcinoma, 2900.0 kIU/mL. |